FAU.de
Deutsch
Login
Home
Publications
Research Grants
Inventions & Patents
Awards
Additional Research Activities
Faculties & Institutions
Research Areas
Professur für Molekulare Urologie
Friedrich-Alexander-Universität Erlangen-Nürnberg
Medizinische Fakultät
Einrichtungen, die zum Universitätsklinikum Erlangen gehören
Urologische Klinik
Lehrstuhl für Urologie
Overview
Publications
(69)
Research Grants
(3)
Types of publications
Toggle all
Journal article
Journal article
Book chapter / Article in edited volumes
Book chapter / Article in edited volumes
Authored book
Authored book
Translation
Translation
Thesis
Thesis
Edited Volume
Edited Volume
Conference contribution
Conference contribution
Other publication type
Other publication type
Unpublished / Preprint
Unpublished / Preprint
Publication year
From
To
Abstract
Journal
Filters (inactive)
Integration of spatial pd-l1 expression with the tumor immune microenvironment outperforms standard pd-l1 scoring in outcome prediction of urothelial cancer patients (2021)
Weyerer V, Strissel P, Strick R, Sikic D, Geppert CI, Bertz S, Lange F, et al.
Journal article, Original article
Gp88/pgrn serum levels are associated with prognosis for oral squamous cell carcinoma patients (2021)
Greither T, Steiner T, Bache M, Serrero G, Otto S, Taubert H, Eckert AW, Kappler M
Journal article
Endogenous Retroviral-K Envelope Is a Novel Tumor Antigen and Prognostic Indicator of Renal Cell Carcinoma (2021)
Weyerer V, Strissel P, Stohr C, Eckstein M, Wach S, Taubert H, Brandl L, et al.
Journal article, Original article
Bladder Tumor Subtype Commitment Occurs in Carcinoma In Situ Driven by Key Signaling Pathways Including ECM Remodeling (2021)
Wullweber A, Strick R, Lange F, Sikic D, Taubert H, Wach S, Wullich B, et al.
Journal article
Tert promoter mutation analysis of whole-organ mapping bladder cancers (2021)
Weyerer V, Eckstein M, Strissel P, Wullweber A, Lange F, Tögel L, Geppert CI, et al.
Journal article
Immune Cell-Associated Protein Expression Helps to Predict Survival in Muscle-Invasive Urothelial Bladder Cancer Patients after Radical Cystectomy and Optional Adjuvant Chemotherapy (2021)
Taubert H, Eckstein M, Epple E, Jung R, Weigelt K, Lieb V, Sikic D, et al.
Journal article
The Prognostic Value of FGFR3 Expression in Patients with T1 Non-Muscle Invasive Bladder Cancer (2021)
Sikic D, Taubert H, Breyer J, Eckstein M, Weyerer V, Keck B, Kubon J, et al.
Journal article
Utility of stromal tumor infiltrating lymphocyte scoring (sTILs) for risk stratification of patients with muscle-invasive urothelial bladder cancer after radical cystectomy (2021)
Sikic D, Weyerer V, Geppert CI, Bertz S, Lange F, Taubert H, Wach S, et al.
Journal article
High expression of ERBB2 is an independent risk factor for reduced recurrence-free survival in patients with stage T1 non-muscle-invasive bladder cancer (2021)
Sikic D, Eckstein M, Weyerer V, Kubon J, Breyer J, Roghmann F, Kunath F, et al.
Journal article
Prognostic Role of FGFR Alterations and FGFR mRNA Expression in Metastatic Urothelial Cancer Undergoing Checkpoint Inhibitor Therapy (2021)
Tully KH, Jütte H, Wirtz RM, Jarczyk J, Santiago-Walker A, Zengerling F, Breyer J, et al.
Journal article
‹
1
2
3
4
5
...
7
›